GlycoMimetics, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.62
+1.35 (10.17%)
At close: Jun 18, 2025, 4:00 PM
14.39
-0.23 (-1.57%)
After-hours: Jun 18, 2025, 6:41 PM EDT
GlycoMimetics Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$22.00
Upside
+50.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Initiates $22 | Buy | Initiates | $22 | +50.48% | Jun 18, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2021 |
| Raymond James | Raymond James | Buy Maintains $285 → $270 | Buy | Maintains | $285 → $270 | +1,746.79% | Aug 6, 2021 |
| Raymond James | Raymond James | Buy Maintains $270 → $285 | Buy | Maintains | $270 → $285 | +1,849.38% | Apr 29, 2021 |
| Piper Sandler | Piper Sandler | Buy Initiates $225 | Buy | Initiates | $225 | +1,438.99% | Feb 10, 2021 |
| Raymond James | Raymond James | Buy Maintains $300 → $270 | Buy | Maintains | $300 → $270 | +1,746.79% | Feb 4, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $660 → $188 | Strong Buy → Hold | Downgrades | $660 → $188 | +1,182.49% | Jun 21, 2018 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $285 → $735 | Strong Buy | Maintains | $285 → $735 | +4,927.36% | Feb 12, 2018 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $150 → $1,125 | Strong Buy | Maintains | $150 → $1,125 | +7,594.94% | Feb 9, 2018 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $285 | Strong Buy | Initiates | $285 | +1,849.38% | Dec 8, 2017 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | +925.99% | Jun 12, 2017 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $165 | Strong Buy | Initiates | $165 | +1,028.59% | Jun 6, 2017 |